The Aprea Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded in 2002 and is headquartered in Boston, MA.
What was Aprea Therapeutics’s price range in the past 12 months?
Aprea Therapeutics lowest stock price was $3.88 and its highest was $31.45 in the past 12 months.
What is Aprea Therapeutics’s market cap?
Aprea Therapeutics’s market cap is $92.59M.
What is Aprea Therapeutics’s price target?
The average price target for Aprea Therapeutics is $7.67. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $10.00 ,the lowest forecast is $6.00. The average price target represents 75.51% Increase from the current price of $4.37.
What do analysts say about Aprea Therapeutics?
Aprea Therapeutics’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
When is Aprea Therapeutics’s upcoming earnings report date?
Aprea Therapeutics’s upcoming earnings report date is Aug 17, 2021 which is in 21 days.
How were Aprea Therapeutics’s earnings last quarter?
Aprea Therapeutics released its earnings results on May 06, 2021. The company reported -$0.456 earnings per share for the quarter, beating the consensus estimate of -$0.492 by $0.036.
Is Aprea Therapeutics overvalued?
According to Wall Street analysts Aprea Therapeutics’s price is currently Undervalued.
Does Aprea Therapeutics pay dividends?
Aprea Therapeutics does not currently pay dividends.
What is Aprea Therapeutics’s EPS estimate?
Aprea Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aprea Therapeutics have?
Aprea Therapeutics has 21,190,000 shares outstanding.
What happened to Aprea Therapeutics’s price movement after its last earnings report?
Aprea Therapeutics reported an EPS of -$0.456 in its last earnings report, beating expectations of -$0.492. Following the earnings report the stock price went down -0.922%.
Which hedge fund is a major shareholder of Aprea Therapeutics?
Currently, no hedge funds are holding shares in APRE